Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

CHIR

Chiron (CHIR)

Chiron (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CHIR
DateTimeSourceHeadlineSymbolCompany
06/21/200610:50AMPR Newswire (US)Bayer Diagnostics Receives FDA Approval for First Fully-Automated Human Immunodeficiency Virus (HIV) Antibody TestNASDAQ:CHIRChiron (MM)
04/19/200612:11PMBusiness WireChiron Shareholders Approve Novartis AcquisitionNASDAQ:CHIRChiron (MM)
04/12/20066:54PMPR Newswire (US)Standard & Poor's Announces Changes to U.S. IndicesNASDAQ:CHIRChiron (MM)
04/11/20068:16PMPR Newswire (US)/C O R R E C T I O N -- NASDAQ/NASDAQ:CHIR
04/11/20067:32PMPR Newswire (US)Akamai Technologies, Inc. to Join the NASDAQ-100 Index Beginning April 20, 2006NASDAQ:CHIRChiron (MM)
04/11/20068:00AMBusiness WireChiron Announces Initiation of Phase 1 Trial for CHIR-265 In Melanoma; Clinical Testing of Novel Oncology Compound Begins in PaNASDAQ:CHIRChiron (MM)
04/05/20064:05PMBusiness WireProxy Advisory Services Recommend Shareholders Vote in Favor of Chiron's Amended Merger Agreement with NovartisNASDAQ:CHIRChiron (MM)
04/03/200612:22PMBusiness WireChiron Announces Amended Merger Agreement with Novartis; Novartis to Acquire All Outstanding Chiron Shares for $48.00 Per ShareNASDAQ:CHIRChiron (MM)
03/31/200612:45AMBusiness WireChiron Statement on Recommendations by Proxy Advisory ServicesNASDAQ:CHIRChiron (MM)
03/16/20069:00AMBusiness WireChiron Recalls and Withdraws MORUPAR(R) MMR Vaccine from Italian and Developing World Markets -- Chiron Also Revises 2005 AdjusNASDAQ:CHIRChiron (MM)
03/15/20064:27PMBusiness WireChiron Response to ValueAct LetterNASDAQ:CHIRChiron (MM)
03/02/20061:30PMBusiness WireCORRECTING and REPLACING Chiron Schedules Special Meeting of Stockholders to Approve Merger With NovartisNASDAQ:CHIRChiron (MM)
03/02/20068:30AMBusiness WireChiron Schedules Special Meeting of Stockholders to Approve Merger With NovartisNASDAQ:CHIRChiron (MM)
02/24/20064:02PMBusiness WireChiron Confirms Proposed Purchase of BETASERON Assets by Schering AG Under Change-in-Control OptionNASDAQ:CHIRChiron (MM)
02/24/20064:01PMBusiness WireChiron Announces Pandemic Influenza Vaccine Contract with the UK Government; Chiron Submits Pandemic Influenza Vaccine ``Mock-UNASDAQ:CHIRChiron (MM)
02/24/20064:01PMBusiness WireChiron Updates Delivery Expectations for U.S. Government H5N1 Vaccine Stockpile ContractNASDAQ:CHIRChiron (MM)
02/07/20068:00AMBusiness WireChiron Announces Termination of SEC InvestigationNASDAQ:CHIRChiron (MM)
02/06/20069:00PMBusiness WireChiron Receives European Commission Approval for Proposed Merger With NovartisNASDAQ:CHIRChiron (MM)
02/02/20068:00AMBusiness WireChiron Foundation Awards Grants to National Organizations Promoting Improved Quality of Life for Cancer and Lung Transplant PatiNASDAQ:CHIRChiron (MM)
01/31/20064:01PMBusiness WireChiron Reports 2005 Adjusted Earnings of $1.34 Per Share, GAAP Earnings of $0.97 Per Share; FLUVIRIN(R) Influenza Virus VaccineNASDAQ:CHIRChiron (MM)
01/23/20064:33PMBusiness WireCubicin(R) Granted Marketing Approval in Europe; First-in-Class Antibiotic Approved for Treatment of Complicated Skin and Soft-TNASDAQ:CHIRChiron (MM)
01/23/20064:00PMPR Newswire (US)ArcaEx Tech 100 Index(R) Announces Change to Index ComponentsNASDAQ:CHIRChiron (MM)
01/17/20068:00AMBusiness WireChiron to Release Earnings on Tuesday, January 31, 2006; Conference Call/Audio Webcast to FollowNASDAQ:CHIRChiron (MM)
01/05/20068:00AMBusiness WireChiron to Present at 24th Annual JPMorgan Healthcare ConferenceNASDAQ:CHIRChiron (MM)
01/05/20068:00AMBusiness WireChiron Foundation Awards Grants to Seven Organizations Committed to Fighting Global Health ThreatsNASDAQ:CHIRChiron (MM)
10/31/20055:02AMBusiness WireChiron Announces Merger Agreement with Novartis; Novartis to Acquire Outstanding 58 Percent of Chiron Shares for $45.00 Per SharNASDAQ:CHIRChiron (MM)
10/28/20059:00AMBusiness WireChiron Announces Promising Data from Clinical Study of Adjuvanted Avian Influenza Vaccine; Results Confirm Previous Clinical StuNASDAQ:CHIRChiron (MM)
10/27/20051:46PMBusiness WireChiron to Supply United States with Pandemic Influenza Vaccine for Stockpile; Contract with U.S. Department of Health & Human SeNASDAQ:CHIRChiron (MM)
10/25/20054:00PMBusiness WireChiron Reports Third-Quarter 2005 Adjusted Earnings of $0.38 per Share, GAAP Earnings of $0.27 per ShareNASDAQ:CHIRChiron (MM)
10/25/20059:00AMBusiness WireChiron Initiates U.S. Phase I/II Study of Influenza Cell Culture VaccineNASDAQ:CHIRChiron (MM)
 Showing the most relevant articles for your search:NASDAQ:CHIR